Radiolabelled IV and Oral Metabolism Study of F901318
Status:
Withdrawn
Trial end date:
2019-07-01
Target enrollment:
Participant gender:
Summary
Open label radiolabelled metabolism study of intravenous and oral solution forms of F901318.
Five healthy male subjects will receive IV and five will receive an oral solution. Blood,
urine and faeces will be collected over a period adequate to obtain 90% recovery of parent
compound and to determine the metabolic profile of both IV and oral forms.